Sysematic review of economic evaluation of the first line treatment for metastasis renal cell carcinoma (mRCC)
mRCC is the unmet medical need and current treatment with interferon can yield a modest result in term of progression free survival (PFS) and overall survival (OS). Although the Food and Drug Administration has granted fast track approval for new targeted therapy for mRCC, the cost-effectiveness inf...
Saved in:
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/62503 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Language: | English |